Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era

A Alperovich, C Batlevi, K Smith, Z Ying, JD Soumerai… - 2016 - ashpublications.org
Introduction In their lifetime, patients with follicular lymphoma frequently require multiple
treatments, which have improved their survival over the past few decades. The expected …

[HTML][HTML] Benchmark of Progression Free Survival for Multiple Lines of Therapy in Follicular Lymphoma Treated in the Rituximab Era

A Alperovich, C Batlevi, K Smith, Z Ying, JD Soumerai… - Blood, 2016 - Elsevier
Introduction In their lifetime, patients with follicular lymphoma frequently require multiple
treatments, which have improved their survival over the past few decades. The expected …